Summary
Mast Therapeutics, Inc. (Mast Therapeutics), formerly known as ADVENTRX Pharmaceuticals, Inc, is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of pharmaceuticals. It develops drug candidates for the treatment of life threatening diseases with unmet medical need. The company’s lead product MST-188 is being developed for the treatment of conditions such as endothelial dysfunction and/or impaired blood flow. Its pipeline includes development programs in the areas of adjunctive thrombolytic therapy, heart failure, resuscitation and major trauma. The company develops MST-188 utilizing its proprietary technology molecular adhesion and sealant technology (MAST). The company is headquartered in San Diego, California, the US.
Mast Therapeutics, Inc. (MSTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ADVENTRX Pharma and Pierre Fabre Medicament Enter into Agreement for ANX-188 10
Licensing Agreements 11
ADVENTRX Pharma Enters Into Licensing Agreement With Theragence 11
Equity Offering 13
Mast Therapeutics Raises USD8 Million in Public Offering of Units 13
Mast Therapeutics to Raise up to USD30 Million in Public Offering of Shares 15
Mast Therapeutics Raises USD15 Million in Public Offering of Series A Units 17
Mast Therapeutics Raises USD6 Million in Public Offering of Series B Units 19
Mast Therapeutics Completes Public Offering Of Units For US$28 Million 21
ADVENTRX Files Registration Statement For Public Offering Of Securities For US$150 Million 23
ADVENTRX Pharma Completes Underwritten Public Offering Of Common Stock For US$17 Million 25
ADVENTRX Pharma Completes Registered Direct Offering Of Its Units For US$22.5 Million 27
ADVENTRX Completes Private Placement Of Series F Convertible Preferred Stock For US$19 Million 29
ADVENTRX Pharma Completes Placement Of Series E Preferred Stock For US$19 Million 31
Acquisition 33
Mast Therapeutics Completes Acquisition Of Aires Pharma 33
Adventrx Pharma Completes Acquisition Of SynthRx From CytRx 35
ADVENTRX To Acquire A Pharma Company 37
Mast Therapeutics, Inc. - Key Competitors 38
Key Employees 39
Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014 1
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Mast Therapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
ADVENTRX Pharma and Pierre Fabre Medicament Enter into Agreement for ANX-188 10
ADVENTRX Pharma Enters Into Licensing Agreement With Theragence 11
Mast Therapeutics Raises USD8 Million in Public Offering of Units 13
Mast Therapeutics to Raise up to USD30 Million in Public Offering of Shares 15
Mast Therapeutics Raises USD15 Million in Public Offering of Series A Units 17
Mast Therapeutics Raises USD6 Million in Public Offering of Series B Units 19
Mast Therapeutics Completes Public Offering Of Units For US$28 Million 21
ADVENTRX Files Registration Statement For Public Offering Of Securities For US$150 Million 23
ADVENTRX Pharma Completes Underwritten Public Offering Of Common Stock For US$17 Million 25
ADVENTRX Pharma Completes Registered Direct Offering Of Its Units For US$22.5 Million 27
ADVENTRX Completes Private Placement Of Series F Convertible Preferred Stock For US$19 Million 29
ADVENTRX Pharma Completes Placement Of Series E Preferred Stock For US$19 Million 31
Mast Therapeutics Completes Acquisition Of Aires Pharma 33
Adventrx Pharma Completes Acquisition Of SynthRx From CytRx 35
ADVENTRX To Acquire A Pharma Company 37
Mast Therapeutics, Inc., Key Competitors 38
Mast Therapeutics, Inc., Key Employees 39
Mast Therapeutics, Inc., Subsidiaries 40
List of Figures
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Mast Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
